LFST: financial statements from SEC — TradeAlmanac

LFST

LifeStance Health Group, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Dec 31, 2025	Dec 31, 2024
Revenue	1.42bn	1.25bn
Selling, general and administrative	382m	363m
Operating expenses	1.40bn	1.28bn
Operating income	24m	−32m
Pre-tax income	12m	−58m
Income tax	3m	−170,000
Net income	10m	−57m
Earnings per share	0.03	−0.15
Earnings per share, diluted	0.02	−0.15
Weighted average shares	386m	379m
Weighted average shares, diluted	391m	379m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	195m	249m	204m	189m	134m	155m	103m	87m
Receivables	123m	96m	121m

Cash flow

Metric	Dec 31, 2025	Dec 31, 2024
Operating cash flow	146m	107m
Depreciation and amortisation	55m	71m
Share-based compensation	75m	76m
Capital expenditure	36m	22m
Investing cash flow	−36m	−22m
Financing cash flow	−16m

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)